Abstract
Immunosuppressive drugs have two principal applications in clinical medicine. They are used in organ transplantation and autoimmune disease. The chemical suppression of the immune response has played an important part in human organ transplantation. Except where identical twins are involved, it is allogeneic grafts that are transplanted. Even with good tissue matching, there is some degree of histocompatibility difference between donor and recipient. In general, the less the histocompatibility difference the longer will be the survival of the grafted organ (van Rood, 1969; Festenstein et al., 1971; Sachs et al., 1971). Survival is further improved by the use of immunosuppressive drugs to abolish or impair the allograft rejection reaction of the recipient (Murray et al., 1963). The rationale for the use of drugs in a transplant situation is clear, and based on sound immunological considerations. In the case of autoimmune disease, however, the argument for the use of immunosuppressive drugs is less cogent. Many diseases are believed to be autoimmune in nature, that is, they are presumed to represent instances of humoral and cell-mediated immune reactivity within the body against antigenic determinants carried by normal tissue. Such an aberrant immune response against self is considered to be both initially responsible for the pathogenesis of the disease and for persisting tissue destruction during the later course of it.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramowicz, M., Barnett, H.L., Edelmann, C.M., Jr., Greifer, I., Kobayashi, O., Arnedi, G.C., Barron, B.A., Gordillo, P.G., Hallman, N., Tiddens, H.A.: Controlled trial with azathioprine in children with nephrotic syndrome. A report for the International Study of Kidney Disease in Children. Lancet I, 959–961 (1970).
Adams, D.A., Gordon, A., Maxwell, M.H.: Azathioprine treatment of immunological renal disease. J. Amer. med. Assoc. 199, 459–463 (1967).
Adelsberger, B., Sinios, A., Deicher, H.: Suppression der Transplantationsreaktion durch gleichzeitige Gabe von Azathioprin und Prednisolon. Zeitschrift für Immunitätsforschung. Allergie klin. Immunol. 139, 277–289 (1970).
Alarcon-Segovia, D., Mayorga-Cortes, A., Wolpert, E.: Primary biliary cirrhosis. Prompt relief of pruritus with azathioprine treatment. J. Amer. med. Assoc. 214, 367–368 (1970).
Aldo, M.A., Benson, M.D., Comerford, F.R., Cohen, A.S.: Treatment of Wegener’s granulomatosis with immunosuppressive agents. Arch, intern. Med. 126, 298–305 (1970).
Alepa, F. P., Zvaifler, N.J., Sliwtnski, A.J.: Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis. Arthritis Rheum. 13, 754–760 (1970).
Arumugam, S., Nimmannit, S., Enquist, I.F.: The effect of immunosuppression on wound healing. Surg. Gynec. Obst. 133, 72–74 (1971).
Asmundsson, T., Kilburn, K.H., Laszlo, J., Krock, C.J.: Immunosuppressive therapy of asthma. J. Allergy 47, 136–147 (1971).
Aungst, C.W., Lessmann, E.M.: Wegener’s granulomatosis treated with nitrogen mustard. N. Y. J. Med. 62, 3302–3310 (1962).
Bach, F.H., Albertini, R.J., Anderson, J.L., Joo, P., Bortin, M.M.: Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet II, 1364–1366 (1968).
Bach, J.F., Dardenne, M., Fournier, C.: In vitro evaluation of immunosuppressive drugs. Nature (Lond.) 222, 998–999 (1969).
Balakrishnan, S.L., Armstrong, D., Rubin, A.L., Stenzel, K.H.: Cytomegalovirus infection after renal transplantation. J. Amer. med. Assoc. 207, 1712–1714 (1969).
Bardana, E.J., Porter, G.A., Pirofsky, B., Gourley, R.T., Bayrakci, C.: Azathioprine in steroid-insensitive nephropathy. Amer. J. Med. 49, 789–800 (1970).
Barnard, C.N.: Human heart transplantation. Canad. med. Ass. J. 100, 91–104 (1969).
Barratt, T.M., Soothill, J.F.: Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet II, 479–482 (1970).
Baum, J., Vaughan, J.: Immunosuppressive drugs in rheumatoid arthritis. Ann. intern. Med. 71, 202–204 (1969).
Beedleman, B.: Wegener’s granulomatosis. J. Amer. med. Assoc. 186, 827–830 (1963).
Bell, P.R.F., Briggs, J.D., Calman, K.C., Patón, A.M., Wood, R.F.M., MacPherson, S.G., Kyle, K.: Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet I, 876–880 (1971).
Beutner, E.H., Jordon, R.E., Chorzelski, T.P.: Autoantibodies in pemphigus vulgaris: response to an intercellular substance of epidermis. J. Amer. med. Assoc. 192, 682–688 (1965).
Booth, L.J., Aber, G.M.: Immunosuppressive therapy in adults with proliferative glomerulonephritis. Lancet II, 1010–1013 (1970).
Bortin, M.M.: A compendium of reported human bone marrow transplants. Transplantation 9, 571–587 (1970).
Botha, M.C.: Leucocyte-antigen matching in donor selection for heart transplantation. Lancet II, 508–512 (1969).
Bouroncle, B.A., Doan, C. A.: Treatment of refractory idiopathic thrombocytopenic purpura. J. Amer. med. Assoc. 207, 2049–2052 (1969).
Bouroncle, B.A., Smith, E.J., Cuppage, F.E.: Treatment of Wegener’s granulomatosis with Imuran. Amer. J. Med. 42, 314–318 (1967).
Bowen, G.E., Irons, G.V., Jr., Rhodes, J.B., Kibsner, J.B.: Early experience with azathioprine in ulcerative colitis. J. Amer. med. Assoc. 195, 460–464 (1966).
Bravo, J.F., Hebman, J.H., Smyth, C.J.: Musculoskeletal disorders after renal homo-transplantation. Ann. intern. Med. 66, 87–104 (1967).
Brendel, W., Land, W., Hopp, U., Seifert, J.: Induction of tolerance in man to horse-IgG. Lancet II, 1141–1142 (1969).
Brooke, B.N., Hoffmann, D.C., Swarbrick, E.T.: Azathioprine for Crohn’s disease. Lancet II, 612–615 (1969).
Brooke, B.N., Javett, S.L., Davison, O.W.: Further experience with azathioprine for Crohn’s disease. Lancet II, 1050–1053 (1970).
Brunstetter, F.H., Claman, H.N.: Impairment of delayed hypersensitivity in uremic patients by antilymphocyte serum. Transplantation 6, 485–487 (1968).
Buckley, C.E., III, Gills, J.P., Jr.: Cyclophosphamide therapy of peripheral uveitis. Arch. intern. Med. 124, 29–35 (1969a).
Buckley, C.E., III, Gills, J.P., Jr.: Cyclophosphamide therapy of Behcet’s disease. J. Allergy 43, 273–283 (1969b).
Burnet, F.M.: The concept of immunological surveillance. Progr. exp. Tumor. Kes. 13, 1–27 (1970).
Burton, J.L., Greaves, M.W., Marks, J., Dawber, R.P.R.: Azathioprine in pemphigus vulgaris. Brit. med. J. 3, 84–86 (1970).
Butler, W.T., Rossen, R.D., Knight, V., Brooks, E.B., Nora, J.J., Leachman, R.D., Morgen, R.O., Judd, K., Trentin, J.J., Cooley, B.A., Debakey, M.E.: Antilymphocyte globulin turnover rates in heart transplant patients. Clin. Res. 17, 72 (1969).
Calne, R.Y.: Inhibition of the rejection of renal homografts in dogs by purine analogues. Transplant. Bull. 28, 65–81 (1961).
Calne, R. Y., Alexandre, G.P. J., Murray, J.E.: A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann. N. Y. Acad. Sci. 99, 743–761 (1962).
Calne, R.Y., Evans, D.B., Herbertson, B.M., Joysey, V., McMillan, R., Maginn, R.R., Millard, P.R., Pena, J.R., Salaman, J.R., White, H. J.O., Withycombe, J.F.R., Yoffa, D.E.: Survival after renal transplantation in man: an interim report on 54 consecutive transplants. Brit. med. J. 2, 404–406 (1968).
Calne, R.Y., Williams, R., Dawson, J.L., Ansell, I.D., Evans, D.B., Flute, P.T., Herbertson, P.M., Joysey, V., Keates, G.H.W., Knill-Jones, R.P., Mason, S.A., Millard, P.R., Pena, J.R., Pentlow, B.D., Salaman, J.R., Sells, R.A., Cullum, P.A.: Liver transplantation in man. IL A report of two orthotopic liver transplants in adult recipients. Brit. med. J. 4, 541–546 (1968).
Cameron, J.S., Robinson, R., Boulton-Jones, M., Ogg, C.: Treatment of lupus nephritis with cyclophosphamide. Lancet II, 846–849 (1970).
Capizzi, R.L., Bertino, J.R.: Methotrexate therapy of Wegener’s granulomatosis. Ann. intern. Med. 74, 74–79 (1971).
Chanmougan, D., Schwartz, R.S.: Enhancement of antibody synthesis by 6-mercaptopurine. J. exp. Med. 124, 363–379 (1966).
Chaouat, Y., Paquet, J., Pelisson, J., Kanovttch, B., Rascorscki, S.: Le cyclophosphamide au long cours à petites doses dans le traitement des rheumatismes inflammatoires graves. Rev. Rhum. 35, 649–656 (1968).
Chatty, M.E., Deodhar, S.D.: Myocardial changes and kidney transplantation. Lesions in patients receiving immunosuppressive therapy. Arch. Path. 88, 602–608 (1969).
Chisholm, G.D., Papadimitriou, M., Kulatilake, A.E., Shackman, R.: The diagnosis of renal allotransplants in man. Lancet I, 904–906 (1969).
Christian, C.L.: Immune-complex disease. New Engl. J. Med. 280, 878–884 (1969).
Clarkson, A.R., Morton, J.B., Cash, J.D.: Urinary fibrin/fibrinogen degradation products after renal homotransplantation. Lancet II, 1220–1223 (1970).
Coates, A.: Cyclophosphamide in pregnancy. Aust. N. Z. Obstet. Gynaec. 10, 33–34 (1970).
Coe, R. O., Bull,P.E.: Cirrhosis associated with methotrexate treatment of psoriasis. J. Amer. med. Assoc. 206, 1515–1520 (1968).
Cohen, M.L., Weiss, E.B., Monaco, A.P.: Successful treatment of Pneumocystis carinii and Nocardia asteroides in a renal transplant patient. Amer. J. Med. 50, 269–276 (1971).
Congdon, C.C: Bone marrow transplantation. Science 171, 1116–1124 (1971).
Cooke, W.T.: Azathioprine in Crohn’s disease. Lancet II, 1195–1196 (1970).
Cooperating Clinics Committee of the American Rheumatism Committee: A controlled trial of cyclophosphamide in rheumatoid arthritis. New Engl. J. Med. 17, 883–889 (1970).
Cooley, D.A., Bloodwell, R.D., Hallman, G.L., Leachman, R.D., Nora, J.J., Milam, J.D.: Cardiac transplantation: general considerations and results. Ann. Surg. 169, 892–903 (1969).
Cooley, D.A., Bloodwell, R.D., Hallman, G.L., Nora, J.J., Harrison, G.M., Leachman, R.D.: Organ transplantation for advanced cardiopulmonary disease. Ann. Thorac. Surg. 8, 30–46 (1969).
Coppola, E.D., Hemstreet, G.P., Villegas, G.R.: Pharmacological treatment. In: Bertelli, A., Monaco, A.P. (Eds.): Organ and tissue transplantation,P. 79. Amsterdam: Excerpta Medica Foundation 1970.
Corley, C.C., Jr., Lessner, H.E., Larsen, W.E.: Azathioprine therapy of “autoimmune” diseases. Amer. J. Med. 41, 404–412 (1966).
Craig, S.R., Rosenberg, E.W.: Methotrexate-induced carcinoma ? Arch. Derm. 103, 505–506 (1971).
Curless, R. G.: Methotrexate in young women with psoriasis. New Engl. J. Med. 285, 296–297 (1971).
Dameshek, W.: Treatment of autoimmune disease with antipurine drugs. Blood 20, 119 (1962).
Deduve, C.: In: Thomas,L., Uhr, J.W., Grant, L. (Eds.): Injury, inflammation and immunity. Baltimore: Williams and Wilkins 1964.
Degowin, R.L., Oda, Y., Evans, R.H.: Nephritis and lung hemorrhage, Goodpasture’s syndrome. Arch, intern. Med. 111, 62–68 (1963).
De Kontng, J., van Bekkum, D.W., Dicke, K.A., Dooren, L. J., van Rood, J.J., Radl, J.: Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet I, 1223–1227 (1969).
Demis, D.J., Brown, CS., Crosby, W.H.: Thioguanine in the treatment of certain autoimmune immunologic and related diseases. Amer. J. Med. 37, 195–205 (1964).
Denman, E.J., Denman, A.M., Greenwood, B.M., Gall, D., Heath, R.B.: Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann. rheum. Dis. 29, 220–231 (1970).
De Seze, S., Bedoiseau, M., Debeyre, N., Kahn, M.P.: Résultats de la thérapeutique a visée immunodépressive chez 40 malades atteints de polyarthrite rheumatoide grave. Sem. Hop. Paris 43, 3084–3091 (1967).
Diaz, C.J., Garcia, E.L., Merchante, A., Perianes, J.: Treatment of rheumatoid arthritis with nitrogen mustard: preliminary report. J. Amer. med. Assoc. 147, 1418–1419 (1951).
Dixon, F.J.: The pathogenesis of glomerulonephritis. Amer. J. Med. 44, 493–498 (1968).
Doak, P.B., Dalton, N.T., Meredith, J., Montgomerie, J.Z., North, J.D.K.: Use of antilymphocyte globulin after cadaveric renal transplantation. Brit. med. J. 4, 522–525 (1969).
Dodson, W.H., Bennett, J.C.: Possible usefulness of azathioprine (Imuran) in severe rheumatoid arthritis. J. clin. Pharmacol. 9, 251–258 (1969).
Dougherty, T.F., Berliner, M.L., Berliner, D.L.: Hormonal influence on lymphocyte differentiation from RES cells. Ann. N. Y. Acad. Sci. 88, 78–82 (1960).
Drinkard, J.P., Stanley, T.M., Dornfeld, L., Austin, R.C., Barnett, E.V., Pearson, C.M., Vernier, R.L., Adams, D.A., Latta, H., Gonick, H.C: Azathioprine and prednisone in treatment of adults with lupus nephritis. Medicine 49, 411–432 (1970).
Drucker, W.R., Jeejeebhoy, K.N.: Azathioprine: adjunct to surgical therapy of granulomatous enteritis. Ann. Surg. 172, 618–626 (1970).
Dubois, E.L.: Nitrogen mustard in treatment of systemic lupus erythematosus. Arch, intern. Med. 93, 667–672 (1954).
Duncan, D.A., Drummond, K.N., Michael, A. F.: Pulmonary hemorrhage and glomerulonephritis: report of six cases and study of renal lesion by fluorescent antibody technique and electron microscopy. Ann. intern. Med. 62, 920–938 (1965).
Ebringer, A., MacKay, I.R.: Pemphigus vulgaris successfully treated with cyclophosphamide. Ann. intern. Med. 71, 125–127 (1969).
Elion, G.B.: Biochemistry and pharmacology of purine analogues. Fed. Proc. 26, 898–904 (1967).
Epstein, E.H., Croft, J.D.: Cirrhosis following methotrexate administration for psoriasis. Arch. Derm. 100, 531–534 (1969).
Eremin, J., Swaney, W.E., Marshall, V.C.: Avascular necrosis in cadaveric renal allografts. Aust. N. Z. J. Surg. 39, 41–46 (1969).
Everett, D., Newcomer, K.L., Anderson, J., Bergin, J., Overholt, E.L.: Goodpasture’s syndrome. Response to mercaptopurine and prednisone. J. Amer. med. Assoc. 213, 1849–1852 (1970).
Fahey, J.L.: Cancer in the immunosuppressed patient. Ann. intern. Med. 75, 310–312 (1971).
Fahey, J.L., Leonard, E., Churg, J., Godman, G.C: Wegener’s granulomatosis. Amer. J. Med. 17, 168–179 (1954).
Festenstein, H., Oliver, R.T.D., Sachs, J.A., Burke, J.M., Adams, E., Diwer, W., Hyams, A., Pegrum, G.D., Balfour, I. C., Moorhead, J. F.: Multicenter collaboration in 162 tissuetyped renal transplants. The London and regional transplant group, March, 1969 to December, 1970. Lancet II, 225–228 (1971).
Fialkow, P.J., Bryant, J. I., Thomas, E.D., Neiman, P.E.: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet I, 251–255 (1971).
Fine, E.N., Wright, H.T., Jr., Lieberman, E., Gordon, A.: Azathioprine and varicella. J. Amer. med. Assoc. 207, 147–148 (1969).
Fischer, J.A., Schmtd, M.: Treatment of primary biliary cirrhosis with azathioprine. Lancet I, 421–424 (1967).
Flanigan, W.J., Caldwell, F.T., Williams, G. D., Brewer, T.E., Glenn, W.E., Headstream, J.W., Campbell, G.S.: Clinical patterns of renal allograft rejection. Ann. Surg. 173, 733–747 (1971).
Forster, E., Maas, D., Beck, K., Oehlert, W., Bhinbaum, F.: Das histologische Bild der chronisch-aggressiven Hepatitis bei immunsuppressiver Therapie. Dtsch. med. Wschr. 96, 1–5 (1971).
Fosdick, W.M.: Cytotoxic therapy in rheumatoid arthritis. Med. Clin. N. Amer. 52, 747–757 (1968).
Fosdick, W.M., Parsons, J.L., Hill, D.F.: Long-term cyclophosphamide therapy in rheumatoid arthritis. Arth. Kheum. 11, 151–161 (1968).
Friedman, E.A., Gelfand, M., Bernheimer, H.P.: Synergism in immunosuppression. I. Effect of methylprednisolone, azathioprine, chlorambucil and radiation on tetanus antitoxin production. Transplantation 11, 479–486 (1971).
Fulginiti, V.A., Scribner, R., Groth, C.G., Putman, C.W., Brettschneider, L., Gilbert, S., Porter, K.A., Starzl, T.E.: Infection in recipients of liver homografts. New Engl. J. Med. 279, 619–626 (1969).
Gatti, R.A., Good, R. A.: Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28, 89–98 (1971).
Germuth, F.G., Jr.: Role of adrenocortical steroids in infection, immunity and hypersensitivity. Pharmacol. Rev. 8, 1–24 (1956).
Germuth, F.G., Jr., Valdes, A.J., Senterfit, L.B., Pollack, A.D.: A unique influence of cortisone in the transit of specific macromolecules across vascular walls in immune complex disease. Johns Hopkins med. J. 122, 137–153 (1968).
Gewurz, H., Wernick, P.R., Quie, P.G., Good, R.A.: Effects of hydrocortisone succinate on the complement system. Nature (Lond.) 208, 755–757 (1965).
Gleason, R.E., Murray, J.E.: Report from Kidney Transplant Registry: analysis of variables in the function of human kidney transplants. Transplantation 5, 360–373 (1967).
Graw, R.G., Jr., Rogenttne, G.N., Jr., Halterman, R.H., Berard, C., Herzig, G.P., Yankee, R.A., Whang-Peng, J., Kruger, G., Henderson, E.S.: Graft-versus-host reaction complicating HL-A matched bone-marrow transplantation. Lancet II, 1053–1055 (1970a).
Graw, R.G., Jr., Santos, G.W.: Bone-marrow transplantation in patients with leukemia. Transplantation 11, 197–199 (1971).
Graw, R.G. Jr., Whang-Peng, J., Kruger, G., Buckner, C.D., Leventhal, B.G., Berard, C., Henderson, E.S.: Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions. Lancet II, 338–340 (1970).
Greaves, M.W., Burton, J.L., Marks, J., Dawber, R.P.R.: Azathioprine in treatment of bullous pemphigoid. Brit. med. J. 1, 144–145 (1971).
Gross, H., Zwtrner, K.: Immuodepressorische Therapie der chronischaggressiven Hepatitis. Münch. Med. Wschr. 111, 2481–2485 (1969).
Gupta, P.K., Pinn, V.M., Taft, P.D.: Cervical dysplasia associated with azathioprine (Imuran) therapy. Acta cytol. 13, 373–376 (1969).
Harris, C.C.: Malignancy during methotrexate and steroid therapy for psoriasis. Arch. Derm. 103, 501–504 (1971).
Harris, N.S., Merino, G., Najarían, J. S.: Mode of action of antilymphocyte sera (ALS). Transplant. Proc. 3, 797–799 (1971).
Hayslett J.P., Berte, J.B., Kashgarian, M.: Successful treatment of renal failure in Goodpasture’s syndrome. Arch. intern. Med. 127, 953–957 (1971).
Hersh, E.M., Butler, W.T., Rossen, R.D., Morgen, R. O.: Activated lymphocytes (AL): a rapid test to detect allograft rejection. Clin. Res. 18, 425 (1970).
Hersh, E.M., Wong, V.G., Freireich, E. J.: Inhibition of the local inflammatory response in man by antimetabolites. Blood 27, 38–48 (1966).
Hersh, E.M., Wong, V.G., Henderson, E.S., Frehieich, E.J.: Hepatotoxic effect of methotrexate. Cancer 19, 600–606 (1966).
Hill, A.G.S., Cruickshank, B.: A study of antigenic components of kidney tissue. Brit. J. exp. Path. 34, 27–34 (1953).
Hill, R.B., Jr., Dahrling, B.E., Starzl, T.E., Rifkind, D.: Death after transplantation. Amer. J. Med. 42, 327–334 (1967).
Hill, R.B., Jr., Rowlands, D.T., Jr., Rifkind, D.: Infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation. New Engl. J. Med. 271, 1921–1927 (1965).
Hitzig, W.H., Massimo, L.: Treatment of autoimmune hemolytic anemia in children with azathioprine (Imuran). Blood 28, 840–850 (1966).
Hollander, J.L., McCarty, D.J., Jr., Astorga, G., Castro-Murdllo, E.: Studies on the pathogenesis of rheumatoid joint inflammation: I. The “R.A. Cell” and a working hypothesis. Ann. intern. Med. 62, 271–280 (1965).
Hurd, E.R., Snyder, W.B., Ziff, M.: Choroidal nodules and retinal detachments in rheumatoid arthritis: improvement with fall in immunoglobulin levels following prednisolone and cyclophosphamide therapy. Amer. J. Med. 48, 273–278 (1970).
Hurst, H.G.: Pemphigus and pemphigoid: some current concepts. Canad. med. Ass. J. 103, 1279–1282 (1970).
Jarlov, N.V., Sorensen, K.: Behandling af reumatoid arthritis med cyklofosfamid (Endoxin). Ugeskr. Laeg. 133, 587–589 (1971).
Javett, S.L.: Azathioprine in primary sclerosing cholangitis. Lancet I, 810 (1971).
Jensen, M.K.: Chromosome studies in patients treated with azathioprine and amethopterin. Acta med. scand. 182, 445–455 (1967).
Jensen, M.K.: Effect of azathioprine on the chromosome complement of human bone marrow cells. Int. J. Cancer 5, 147–151 (1970).
Jensen, M.K., Soborg, M.: Chromosome aberrations in human cells following treatment with Imuran. Acta med. scand. 179, 249–250 (1966).
Jones, R.A.: Immunosuppressive therapy in ulcerative colitis. Proc. roy. Soc. Med. 62, 499–501 (1969).
Jooste, S.V.: Review. Immunological effects of heterologous antilymphocytic sera. Lymphology 3, 79–103 (1970).
Kahn, M.F., Bedoiseau, M., Deseze, S.: Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis. Proc. roy. Soc. Med. 60, 130–133 (1967).
Kaplan, S.R., Hayslett, J.P., Calabresi, P.: Treatment of advanced Wegener’s granulomatosis with azathioprine and duazomycin A. New Engl. J. Med. 278, 239–244 (1968).
Karpatkin, S., Suskind, G.W.: In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosis. Blood 33, 795–812 (1969).
Kashiwagi, N., Brantigan, C.O., Brettschneider, L., Groth, C.G., Starzl, T.E.: Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann. intern. Med. 68, 275–286 (1968).
Kay, S., Frable, W.J., Hume, D.M.: Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation. Cancer 26, 1048–1052 (1970).
Kelly, W.D., Lillehei, R.C., Aust, J.B., Vario, R.L., Leonard, A.S., Griffen, W.O., Markland, L., Herdman, R.C., Vermer, R.L., Michael, A.F., Levitt, J.: Kidney transplantation: experience at the University of Minnesota Hospitals. Surgery 62, 704–720 (1967).
Kjncaid-Smith, P.: Histological diagnosis of rejection of renal homografts in man. Lancet II, 849–852 (1967).
Koffler, D., Schur, P. H., Kunkel, H.G.: Immunological studies concerning the nephritis of systemic lupus erythematosus. J. exp. Med. 126, 607–624 (1967).
Krakowski, A., Covo, J., Rozanski, Z.: Pemphigus vulgaris. Arch. Derm. 100, 117 (1969).
Kuzemko, J.A., Keidan, M.B.: Treatment of chronic idiopathic thrombocytopenic purpura with azathioprine and prednisone: a clinical trial with three children. Clin. Pediat. 7, 216–219 (1968).
Laborde, M.A., Bach, J.F.: Inhibition et stimulation par Pazathioprine de l’incorporation de thymidine par les lymphocytes en culture mixte. C.R. Acad. Sci. (Paris) 272, 509–512 (1971).
Lance, E.M.: Mode of action of antilymphocyte serum. Fed. Proc. 29, 209–211 (1970).
Laros, R.K., Penner, J.A.: “Refractory” thrombocytopenic purpura treated successfully with cyclophosphamide. J. Lab. clin. Med. 72, 987–988 (1968).
Laros, E.K., Penner, J.A.: “Refractory”’ thrombocytopenic purpura treated successfully with cyclophosphamide. J. Amer. med. Assoc. 215, 445–449 (1971).
Leb, D.E., Kanovitz, B.S., Weisskopf, B.: Azathioprine called mutagenic. J. Amer, med. Assoc. 212, 969–970 (1970).
Lee, S.L., Meiselas, L.E., Zingale, S.B., Richman, S.M.: Effect of 6-mercaptopurine administration on antibody production and clinical course in systemic lupus erythematosus; report of a case. Arthritis Rheum. 4, 56–63 (1961).
Lerman, J., Castleman, B.: Draining ears and renal failure in a thirty-six-year-old man. New Engl. J. Med. 280, 828–834 (1969).
Lerner, R.A., Glassock, R. J., Dixon, F. J.: The role of antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J. exp. Med. 126, 989–1004 (1967).
Lever, W.F., Goldberg, H.S.: Treatment of pemphigus vulgaris with methotrexate. Arch. Derm. 100, 70–78 (1969).
Levitt, J.I.: Deterioration of renal function after discontinuation of long-term prednisone-azathioprine therapy in primary renal disease. New Engl. J. Med. 282, 1125–1127 (1970).
Locher, H., Franz, J.: Chromosomenveränderungen bei Methotrexatebehandlungen. Med. Welt. 34, 1965–1966 (1967).
MacKay, I.R.: Chronic hepatitis: Effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone. Quart. J. Med. 147, 379–392 (1968).
MacKay, I.R., Wall, A.J.: Azathioprine therapy of ulcerative colitis. Amer. J. dig. Dis. 13, 850–851 (1968).
Mackenzie, A.H.: Scleroderma responds to chlorambucil therapy. J. Amer. med. Assoc. 213, 1117–1118 (1970).
MacLean, L.D., MacKinnon, K.G., Inglis, F.G., Dossetor, J.B.: When should renal allografts be removed ? Arch. Surg. 99, 269–274 (1969).
Magil, A., Hancock, D. J., Zabriskie, J.B., Guttmann, R.P., Falk, R.E.: A rapid method of assessment of cellular immunity with human blood leukocytes. Proc. Canad. Fed. Biol. Soc. 14, 152 (1971).
Maker, J.F., Schreiner, G.E.: Treatment of lupus nephritis with azathioprine. Arch, intern. Med. 125, 293–298 (1970).
Matbach, H.L, Epstein, W.L.: Immunologic responses of healthy volunteers receiving azathioprine (Imuran). Int. Arch. Allergy 27, 102–109 (1965).
Malaviya, A.N., Many, A., Schwartz, R.S.: Treatment of dermatomyositis with methotrexate. Lancet II, 485–488 (1968).
Mannick, J.A., Davis, R.C., Cooperband, S.R., Glasgow, A.H., Williams, L.F., Harrington, J.T., Cavallo, T., Schmitt, G.W., Idelson, B.A., Olsson, C.A., Nabseth, D.C: Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation. New Engl. J. Med. 284, 1109–1115 (1971).
Manz, H.J., Dinsdale, H.B., Morrin, P.A.F.: Progressive multifocal leukoencephalopathy after renal transplantation. Ann. intern. Med. 75, 77–81 (1971).
Marmont, A.M., Damasio, E.E., Gori, E.: Vinblastine sulphate in idiopathic thrombocytopenic purpura. Lancet II, 94 (1971).
Mason, M., Curry, H.F.L., Barnes, C.G., Dunne, J.F., Hezleman, B.L., Strickland, I.D.: Azathioprine in rheumatoid arthritis. Brit. med. J. 1, 420–422 (1969).
Mathé, G., Amiel, J.L., Schwarzenberg, L., Choay, J., Trolard, P., Schneider, M., Hayat, M., Schlumberger, J.R., Jasmin, C.: Bone marrow graft in man after conditioning by antilymphocytic serum. Brit. med. J. 2, 131–136 (1970).
Mathison, D.A., Condemi, J.J., Leddy, J.P., Callebame, M.L., Panner, B.J., Vaughan, J.H.: Purpura, arthralgia, and IgM-IgG cryoglobulinemia with rheumatoid factor activity. Response to cyclophosphamide and splenectomy. Ann. intern. Med. 74, 383–390 (1971).
McDonald, J.C., Ritchey, R.J., Fuselier, P.F., Lindsey, E.S., McCracken, B.H.: Sepsis in human renal transplantation. Surgery 69, 189–193 (1971).
McIlvanie, S.K.: Wegener’s granulomatosis: successful treatment with chlorambucil. J. Am. med. Assoc. 197, 90–92 (1966).
McKhann, C.F.: Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 8, 209–212 (1969).
Medawar, P.B.: In: Rapaport, F.T., Dausset, J. (Eds.): Biological effects of heterologous antilymphocyte sera. Human transplantation, pp. 501–509. New York: Grune and Stratton 1968.
Mee, A.D., Evans, D.B.: Antilymphocyte-serum preparations in treatment of renal-allograft rejection. Lancet II, 16–19 (1970).
Melnick, H., Friedman, H.: Inhibition of macrophage-migration as an in vitro correlate of hypersensitivity to a kidney antigen during allograft immunity. Fed. Proc. 29, 785 (1970).
Mertens, H.G., Balzereit, F., Leipert, M.: The treatment of severe myasthenia gravis with immunosuppressive agents. Europ. Neurol. 2, 321–339 (1969).
Meuwissen, H. J., Gatti, R.A., Terasaki, P.L, Hong, R., Good, R.A.: Treatment of lymphogenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. New Engl. J. Med. 281, 691–697 (1969).
Michael, A.F., Vernier, R.L., Drummond, K.N., Levttt, J.L, Herdman, R.C., Fish, A.J., Good, R. A.: Immunosuppressive therapy of chronic renal disease. New Engl. J. Med. 276, 817–828 (1967).
Miller, J.J., III, Cole, L.J.: Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine and actinomycin D. J. exp. Med. 126, 109–125 (1967).
Mitchell, C.G., Smith, M.G.M., Eddleston, A.L.W.F., Williams, R.: Serum immuno-suppressive activity due to azathioprine and its relation to hepatic function after liver transplantation. Lancet I, 1196–1199 (1970).
Moberg, A.W., Gewürz, H., Simmons, R.L., Najarían, J.S.: Desensitization to horse-globulin before immunosuppressive treatment. Lancet II, 214 (1970).
Moens, C., Brocteur, J.: Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study. Acta rheum, scand. 11, 212–220 (1965).
Montgomerie, J.Z., Becroft, D.M.O., Croxson, M.C., Doak, P.B., North, J.D.K.: Herpes-simplex-virus infection after renal transplantation. Lancet II, 867–871 (1969).
Mookerjee, B., Gault, M.H., Dossetor, J.B.: Hyperchloremic acidosis in early diagnosis of renal allograft rejection. Ann. intern. Med. 71, 47–58 (1969).
Moore, T.C., Hume, D.M.: The period and nature of hazard in clinical renal transplantation. I. The hazard to patient survival. Ann. Surg. 170, 1–11 (1969a).
Moore, T.C., Hume, D.M.: The period and nature of hazard in clinical renal transplantation. III. The hazard to transplant kidney survival. Ann. Surg. 170, 25–29 (1969b).
Muller, H.K., Sutherland, R.C., Jamieson, W.J., Deboer, W.G.R.M.: Autoantibodies in bullous pemphigoid. Med. J. Aust. 1, 429–431 (1971).
Muller, S.A., Farrow, G.M., Martalock, D.L.: Cirrhosis caused by methotrexate in the treatment of psoriasis. Arch. Derm. 100, 523–530 (1971).
Munro, A., Bewick, M., Manuel, L., Cameron, J.S., Ellis, F.G., Boulton-Jones, M., Ogg, O.S.: Clinical evaluation of a rosette inhibition test in renal allotransplantation. Brit. med. J. 3, 271–275 (1971).
Murphy, G.P., Hesse, V.E., Reynoso, G.D., Moore, R.H., Cohen, E., Kenny, G.M.: Human renal allotransplants. Value of physical examination, biochemical, hematologic, and immunochemical testing. N. Y. State J. Med. 71, 956–960 (1971).
Murray, J.E., Merrill, J. P., Harrison, J. H., Wilson, R.E., Dammin, G.J.: Prolonged survival of human kidney homograft by immunosuppressive drug therapy. New Engl. J. Med. 268, 1315–1323 (1963).
Musset, R., Pitout, P., Lambert-Netter, A.: Transplantation rénale et grossesse. Presse Med. 79, 1273–1276 (1971).
Najarian, J.S., Simmons, R.L.: The clinical use of antilymphocyte globulin. New Engl. J. Med. 285, 158–166 (1971).
Najarian, J.S., Simmons, R.L., Gewürz, H. Moberg, A., Merkel, F., Moore, G.E.: Antiserum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann. Surg. 170, 617–632 (1969).
Nakamoto, S., Straffon, R.A, Kolff, W.J.: Three years’ clinical experience with cadaver kidney transplantation. Transplantation 5, 854–858 (1967).
Ngu, J.L., Barratt, T.M., Soothill, J.F.: Immunoconglutinin and complement changes in steroid sensitive relapsing nephrotic syndrome of children. Clin. exp. Immun. 6, 109–116 (1970).
Nora, J.J., Cooley, D.A., Fernbach, D.J., Rochelle, G.D., Milam, J.D., Montgomery, J.R., Leachman, R.D., Butler, W.T., Rossen, R.D., Bloodwell, R.B., Hallman, G.L., Trenttn, J.J.: Rejection of the transplanted human heart; indexes of recognition and problems in prevention. New Engl. J. Med. 280, 1079–1086 (1969).
Norton, W.L., Suki, W., Strunk, S.: Combined corticosteroid and azathioprine therapy in two patients with Wegener’s granulomatosis. Arch, intern. Med. 121, 554–560 (1968).
O’Rourke, R.A., Eckert, G.E.: Methotrexate-induced hepatic injury in an adult. Arch. intern. Med. 113, 191–194 (1964).
Osgood, E.E.: Cross-immunity, not autoimmunity, as the mechanism of rheumatoid arthritis and related diseases. In: Stephens, C.A.L., Jr., Stanfield, A.B. (Eds.): Cellular concepts in rheumatoid arthritis, pp. 137–154. Springfield: Charles C. Thomas 1966.
Oshima, Y., Shimuzu, T., Yokohari, R., Matsumoto, T., Kano, K., Kagami, T., Nagaya, H.: Clinical studies in Behcet’s syndrome. Ann. rheum. Dis. 22, 36–45 (1963).
Owen, K.: Renal transplantation. Brit. J. Hosp. Med. 2, 1216–1219 (1969).
Page, D., Posen, G., Stewart, T., Harris, J.: Immunologic detection of renal allograft rejection in man: increased DNA synthesis by peripheral lymphoid cells. Transplantation 12, 341–347 (1971).
Parker, J.R., Ellis, F.G., Cameron, J.S., Ogg, C.S.: Detection of rejection of human renal allografts by increased RNA synthesis in peripheral lymphocytes. Proc. Europ. Dialysis Transplant Ass. 7, 331–335 (1970).
Parker, J.R., Mowbray, J.F.: Peripheral blood leucocyte changes during human renal allograft rejection. Transplantation 11, 201–209 (1971).
Paronetto, F., Schaffner, F., Popper, H.: Immunocytochemical and serologic observations in primary biliary cirrhosis. New Engl. J. Med. 271, 1123–1128 (1964).
Patterson, J.F., Norton, R.A., Schwartz, R.S.: Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis. Amer. J. dig. Dis. 16, 327–332 (1971).
Penn, I., Halgrimson, C.G., Starzl, T.E.: De novo malignant tumors in organ transplant recipients. Transplantation Proc. 3, 773–778 (1971).
Pirofsky, B., Bardana, E.J., Jr., Bayracki, C: Antilymphocyte antisera in immunologically mediated renal disease. J. Amer. med. Assoc. 210, 1059–1064 (1969).
Pirofsky, B., Reid, R.H., Bardana, E.J., Jr., Bayracki, C.: Antithymocyte antisera therapy in nonsurgical immunologic disease. Transplant. Proc. 3, 769–772 (1971).
Pletka, P., Cohen, S.L., Hulme, B., Kenyon, J.R., Owen, K., Thompson, A.E., Snell, M., Mowbray, J.F., Porter, K.A., Leigh, D.A., Peart, W.S.: Cadaveric renal transplantation: an analysis of 65 cases. Lancet I, 1–5 (1969).
Posen, G., Harris, J., Page, D., Stewart, T.: Reaction lymphocyte blastogenesis (RLB) in the immunologic assessment of human renal allograft recipients. Proc. E.D.T.A. pp. 270–278, 1971.
Prout, G.R., Jr., Hume, D.M., Lee, H.M., Williams, G.M.: Some urological aspects of 93 consecutive renal homotransplants in modified recipients. J. Urol. 97, 409–425 (1967).
Rattt, J.W.: Wegener’s granulomatosis: treatment with cytotoxic agents and adrenocorticoids. Ann. intern. Med. 74, 344–356 (1971).
Rau, R.: Cyclophosphamid-Behandlung der progredient-chronischen Polyarthritis, unter besonderer Berücksichtigung des sauren a-Glycoproteins und der Immunoglobuline. Dtsch. med. Wschr. 96, 992–1001 (1971).
Renier, J.C., Deshayes, P., Besson, J., Barazer, C.L, Delahaya, D., Bregeon, C.:, Traitement de la polyarthrite rheumatoide par le chlorambucil: à propos de 48 observations. Presse Med. 75, 2527–2530 (1967).
Rhodes, J., Datnton, D., Beck, P.: Azathioprine in Crohn’s disease. Lancet II, 1142 (1970).
Rifkind, D.: Cytomegalovirus infection after renal transplantation. Arch, intern. Med. 116, 554–558 (1965).
Rifkind, D.: The activation of varicella-zoster virus infection by immunosuppressive therapy. J. Lab. clin. Med. 68, 463–474 (1966).
Rifkind, D., Marchioro, T.L., Schneck, S.A., Hill, R.B., Jr: Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Amer. J. Med. 43, 28–38 (1967).
Rifkind, D., Marchioro, T.L., Waddell, W.R., Starzl, T.E.: Infectious diseases associated with renal homotransplantation. I. Incidence, types, and predisposing factors. II. Differential diagnosis and management. J. Amer. med. Assoc. 189, 397–407 (1964).
Riggio, R.R., Schwaetz, G.H., Stenzbl, K.H., Rubin, A.L.: Alpha-2-hyperglobulinaemia as a humoral indicator of the homograft reaction. Lancet I, 1218–1221 (1968).
Rosselet, E., Saudan, Y., Zenklusen, G.: Les effects de Pazathioprine (Imuran) dans la maladie de Behcet. Premiers résultats thérapeutiques. Ophthalmologica (Basel) 156, 218–226 (1968).
Rothenberger, W., Thiele, H.G.: In vitro-Studie zur Pathogenese der primär-chronischen Polyarthritis mittels des Migrations-Inhibitionstests. Klin. Wschr. 48, 1308–1311 (1970).
Ryan, T.J., Boddington, M.M., Spriggs, A.L: Chromosomal abnormalities produced by folic acid antagonists. Brit. J. Derm. 77, 541–555 (1965).
Sachs, J.A., Oliver, R.T.D., Festenstein, H., Blandy, J.P., Salaman, J.R., Balfour, I.C., Pegrum, G.D., Williams, G.B., Hopewell, J.P., Moorhead, J.F., Barnes, A.D., Bewick, M.: International collaboration in renal transplantation. Lancet II, 228–230 (1971).
Salaman, J.R.: Use of radioactive fibrinogen for detecting rejection of human renal transplants. Brit. med. J. 2, 517–521 (1970).
Sampson, D.: Ultrasonic method for detecting rejection of human renal allotransplants. Lancet II, 976–978 (1969).
Scheer, R.L., Grossman, M.A.: Immune aspects of the glomerulonephritis associated with pulmonary hemorrhage. Ann. intern. Med. 60, 1009–1021 (1964).
Schneck, S.A., Penn, L: De-novo brain tumours in renal-transplant recipients. Lancet I, 983–986 (1971).
Sell, S.: Antilymphocyte antibody effects in experimental animals and problems in human use. Ann. intern. Med. 71, 177–196 (1969).
Sharp, H., White, J., Krivit, W.: Methotrexate induced liver injury. Proc. Amer. Ass. Cancer Res. 8, 60 (1967).
Shehadeh, I.H., Carpenter, C.B., Monterio, C.H., Merrill, J.P.: Renal allograft rejection. An analysis of lysozymuria serum complement, lymphocyturia and heterophil antibodies. Arch, intern. Med. 125, 850–857 (1970).
Sheil, A.G.R., Kelly, G.E., Storey, B.G., May, J., Kalowski, S., Mears, D., Rogers, J.H., Johnson, J.R., Charlesworth, J., Stewart, J.H.: Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors. Lancet I, 359–363 (1971).
Shorter, R.G., Hallenbeck, G.A., Nava, C., O’Kane, H.O., Deweerd, J.H., Johnson, W. J.: Antilymphoid sera in renal allotransplantation. Arch. Surg. 97, 323–329 (1968).
Shotton, D., Monie, I.W.: Possible teratogenic effect of chlorambucil on a human fetus. J. Amer. med. Assoc. 186, 74–75 (1963).
Simmons, R.L., Kelly, W.D., Tallent, M.B., Najarian, J.S.: Care of dysgerminoma with widespread metastases appearing after renal transplantation. New Engl. J. Med. 283, 190–191 (1970).
Skoglund, R.R., Schanberger, J.E., Kaplan, J.M.: Cyclophosphamide therapy for severe juvenile rheumatoid arthritis. Amer. J. Dis. Child. 121, 531–533 (1971).
Smith, M.G.M., Eddleston, A.L.W.F., Domínguez, J.A., Evans, D.B. Bewick, M., Williams, R.: Changes in leucocyte migration after renal transplantation. Brit. med. J. 3, 275–278 (1969).
Sokal, J.E., Lessmann, E.M.: Effects of cancer chemotherapeutic agents on the human fetus. J. Amer. med. Assoc. 172, 1765–1771 (1960).
Sokoloff, M.C., Goldberg, L.S., Pearson, CM.: Treatment of corticosteroid-resistant polymyositis with methotrexate. Lancet I, 14–16 (1971).
Solberg, C.O., Meuwissen, H.J., Needham, R.N., Good, R.A., Matsen, J.M.: Infectious complications in bone-marrow transplant patients. Brit. med. J. 1, 18–23 (1971).
Spencer, E.S.: Immunosuppression and cancer. Lancet I, 777–778 (1969).
Stanfield, A.B., Stephens, C.A.L., Jr., Hill, D.F.: Tissue culture investigations in rheumatoid arthritis. In: Stephens, CA.L., Jr., Stanfield, A.B. (Eds.): Cellular concepts in rheumatoid arthritis, pp. 155–177. Springfield: Charles C. Thomas 1966.
Starzl, T.E., Groth, C.G., Brettschneider, L., Penn, I., Fulginiti, V.A., Moon, J.B., Blanchard, H., Martin, A.J., Porter, K.A.: Orthotopic homotransplantation of the human liver. Ann. Surg. 168, 392–415 (1968).
Starzl, T.E., Groth, C., Brettschneider, L., Smith, O.G.V., Penn, I., Kashiwagi, N.: Perspectives in organ transplantation (Proceedings of the Swiss Society of Immunology). Antibiot. Chemother. 15, 349–383 (1969).
Starzl, T.E., Marchioro, T.L., Hutchinson, O.E., Porter, K.A., Cerilli, G.J., Brett-schneider, L.: The clinical use of antilymphocyte globulin in renal transplantation. Transplantation 5, 1100–1105 (1967).
Starzl, T.E., Penn, I., Halgrimson, C.G.: Immunosuppression and malignant neoplasms. New Engl. J. Med. 283, 934–935 (1970).
Starzl, T.E., Penn, I., Schroter, G., Putman, C.W., Halgrimson, C.G., Martineau, G., Amemiyaj H., Groth, C.G.: Cyclophosphamide and human organ transplantation. Lancet II, 70–74 (1971).
Starzl, T.E., Porter, K.A., Andres, G., Halgrimson, C.G., Hurwitz, E., Giles, G., Terasaki, P.I., Penn, I., Schroter, G.T., Lilly, J., Stareie, S.J., Putnam, C.W.: Long-term survival after renal transplantation in humans (with special reference to histocom-patibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG, and recipient malignancy). Ann. Surg. 172, 437–472 (1970).
Steinberg, A.D., Kaltreider, H.B., Staples, P. J., Goetzl, E.J., Talal, N., Decker, J.L.: Cyclophosphamide in lupus nephritis: a controlled trial. Ann. intern. Med. 75, 165–171 (1971).
Stinson, E.B., Bieber, C.P., Griepp, R.B., Clark, D.A., Shitmway, N.E., Remington, J.S.: Infectious complications after cardiac transplantation in man. Ann. intern. Med. 74, 22–36 (1971).
Sttnson, E.B., Dong, E., Jr., Bieber, C.P., Popp, R.L., Shumway, N.E.: Cardiac transplantation in man. II. Immunosuppressive therapy. J. thorac. cardiovasc. Surg. 68, 326–337 (1969a).
Stinson, E.B., Dong, E., Jr., Bieber, C.P., Schroeder, J.S., Shumway, N.E.: Cardiac transplantation in man. I. Early rejection. J. Amer. med. Assoc. 207, 2233–2242 (1969b).
Sunderman, C.R., Pearson, H.A.: Growth effects of long-term antileukemic therapy. J. Pediat. 75, 1058–1062 (1969).
Sussman, L.N.: Azathioprine in refractory idiopathic thrombocytopenic purpura. J. Amer. med. Assoc. 202, 259–263 (1967).
Sutherland, J.M., Light, I.J.: The effect of drugs upon the developing fetus. Pediat. Clin. N. Amer. 12, 781–806 (1965).
Swanson, M.A., Schwartz, R.S.: Immunosuppressive therapy — the relation between clinical response and immunologic competence. New Engl. J. Med. 277, 163–170 (1967).
Taub, R.N., Kochwa, S., Brown, S.M., Rubin, A.D., Dameshek, W.: Antigen-induced immunological tolerance in man to equine anti-human-thymocyte gamma-globulin. Lancet II, 521–523 (1969).
Tennenbaum, J. I., St. Pierre, R.L., Cerilli, G. J.: Evaluation of immunosuppressive therapy and clinical course in renal transplants by in vitro lymphocyte transformation. Transplantation 6, 986–990 (1968).
Theodor, E., Gilon, E., Waks, U.: Treatment of ulcerative colitis with azathioprine. Brit. med. J. 4, 741–743 (1968).
Toledo, T.M., Harper, R.C., Moser, R.H.: Fetal effects during cyclophosphamide and irradiation therapy. Ann. intern. Med. 74, 87–91 (1971).
Trepel, F., Pichlmayr, R., Kimura, J., Brendel, W., Begemann, H.: Therapieversuche mit Antilymphocytenserum bei Autoaggressions-Krankheiten des Menschen. Klin. Wschr. 46, 856–864 (1968).
Tuhy, J.E., Maurice, G.L., Niles, N.R.: Wegener’s granulomatosis. Amer. J. Med. 25, 638–646 (1958).
Uldall, R., Taylor, R., Swtnney, J.: Cyclophosphamide in human organ transplantation. Lancet II, 258–259 (1971).
Van Rood, J.J.: Tissue typing and organ transplantation. Lancet I, 1142–1146 (1969).
Voorhees, J.J., Janzen, M.K., Harrell, E.R., Chakrabarti, S.G.: Cytogenetic evaluation of methotrexate-treated psoriatic patients. Arch. derm. 100, 269–274 (1969).
Walker, D., Gill, T.J., III, Corson, J.M.: Leiomyosarcoma in a renal allograft recipient treated with immunosuppressive drugs. J. Amer. med. Assoc. 215, 2084–2086 (1971).
Walker, J.G., Doniach, D., Roitt, I.M., Sherlock, S.: Serological tests in diagnosis of primary biliary cirrhosis. Lancet I, 827–831 (1965).
Weiss, H.J., Demis, D.J., Elgart, M.L., Brown, E.S., Crosby, W.H.: Treatment of two cases of hyperglobulinemic purpura with thioguanine. New Engl. J. Med. 268, 753–756 (1963).
Weissmann, G.: Lysosomes. New Engl. J. Med. 273, 1143–1149 (1965).
Weksler, M.E., Bull, G., Schwartz, G.H., Stenzel, K.H., Rubin, A.L.: Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin. J. clin. Invest. 49, 1589–1595 (1970).
Weksler, M.E., Schwartz, G., Stenzel, K., Rubin, A.: Anaphylactic reaction to A.L.G. after induction of tolerance. Lancet II, 1361 (1969).
White, J.J., Tanser, P.H., Anthonisen, N.R., Wynands, J.E., Pare, J.A.P., Becklake, M.R., Munro, D.D., MacLean, L.D.: Human lung homotransplantation. Canad. med. Ass. J. 94, 1199–1209 (1966).
White, R. H.R.: Cytotoxic drug therapy in steroid-resistant glomerulonephritis. Proc. roy Soc. Med. 60, 1164–1168 (1967).
Whittingham, S., Mackay, I.R.: The “pemphigus” antibody and immunopathies affecting the thymus. Brit. J. Derm. 84, 1–6 (1971).
Wolff, K., Schreiner, E.: Immunosuppressive Therapie bei Pemphigus vulgaris. Vorläufige Erfahrungen mit Azathioprin (Imurel). Arch. klin. exp. Derm. 235, 63–77 (1969).
Wong, V.G.: Immunosuppressive therapy of ocular inflammatory disease. Arch. Ophthal. 81, 628–637 (1969).
Woodruff, M.F. A.: Antilymphocyte serum: summary and further observations. Transplantation 5, 1127–1133 (1967).
Woodruff, M.F.A., Nolan, B., Robson, J.S., MacDonald, M.K.: Renal transplantation in man; experience in 35 cases. Lancet I, 6–12 (1969).
Worth, P.H.L.: Cyclophosphamide and the bladder. Brit. med. J. 3, 182 (1971).
Yuill, Gr. M., Swinburn, W.R., Liversedge, L. A.: Treatment of polyneuropathy with azathioprine. Lancet II, 854–856 (1970).
Zuhlke, V., Herman, G.: Diagnose der Abstoßungsreaktion transplantierter Nieren durch immunologische Untersuchungen der Harneuveisse. Münch. med. Wschr. 112, 61–64 (1970).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Harris, J.E., Bagai, R.C. (1974). Clinical Utility of Immunosuppressive Agents. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive